GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Diplomat Pharmacy Inc (NYSE:DPLO) » Definitions » Gross Profit

Diplomat Pharmacy (Diplomat Pharmacy) Gross Profit : $309 Mil (TTM As of Sep. 2019)


View and export this data going back to 2014. Start your Free Trial

What is Diplomat Pharmacy Gross Profit?

Diplomat Pharmacy's gross profit for the three months ended in Sep. 2019 was $63 Mil. Diplomat Pharmacy's gross profit for the trailing twelve months (TTM) ended in Sep. 2019 was $309 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Diplomat Pharmacy's gross profit for the three months ended in Sep. 2019 was $63 Mil. Diplomat Pharmacy's Revenue for the three months ended in Sep. 2019 was $1,301 Mil. Therefore, Diplomat Pharmacy's Gross Margin % for the quarter that ended in Sep. 2019 was 4.87%.

Diplomat Pharmacy had a gross margin of 4.87% for the quarter that ended in Sep. 2019 => No sustainable competitive advantage


Diplomat Pharmacy Gross Profit Historical Data

The historical data trend for Diplomat Pharmacy's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diplomat Pharmacy Gross Profit Chart

Diplomat Pharmacy Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Gross Profit
Get a 7-Day Free Trial 140.14 263.24 265.59 274.15 376.01

Diplomat Pharmacy Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 93.36 93.86 79.22 72.73 63.39

Competitive Comparison of Diplomat Pharmacy's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Diplomat Pharmacy's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diplomat Pharmacy's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Diplomat Pharmacy's Gross Profit distribution charts can be found below:

* The bar in red indicates where Diplomat Pharmacy's Gross Profit falls into.



Diplomat Pharmacy Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Diplomat Pharmacy's Gross Profit for the fiscal year that ended in Dec. 2018 is calculated as

Gross Profit (A: Dec. 2018 )=Revenue - Cost of Goods Sold
=5492.524 - 5116.515
=376

Diplomat Pharmacy's Gross Profit for the quarter that ended in Sep. 2019 is calculated as

Gross Profit (Q: Sep. 2019 )=Revenue - Cost of Goods Sold
=1301.197 - 1237.812
=63

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $309 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Diplomat Pharmacy's Gross Margin % for the quarter that ended in Sep. 2019 is calculated as

Gross Margin % (Q: Sep. 2019 )=Gross Profit (Q: Sep. 2019 ) / Revenue (Q: Sep. 2019 )
=(Revenue - Cost of Goods Sold) / Revenue
=63 / 1301.197
=4.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Diplomat Pharmacy  (NYSE:DPLO) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Diplomat Pharmacy had a gross margin of 4.87% for the quarter that ended in Sep. 2019 => No sustainable competitive advantage


Diplomat Pharmacy Gross Profit Related Terms

Thank you for viewing the detailed overview of Diplomat Pharmacy's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Diplomat Pharmacy (Diplomat Pharmacy) Business Description

Traded in Other Exchanges
N/A
Address
4100 South Saginaw Street, Flint, MI, USA, 48507
Diplomat Pharmacy Inc. is active in the U.S. healthcare sector. It provides specialty pharmacy and infusion services, including pharmacy solutions for chronic diseases. The company has two main segments: specialty pharmacy and pharmacy benefit management. Its specialty pharmacy segment offers solutions to dispense, deliver, and dose prescription drugs. The pharmacy benefit management segment offers services to help control pharmacy benefit dollars and maximize quality of care. It derives most of its revenue through prescription drug sales in the United States.
Executives
Brian T Griffin director, officer: Chairman and CEO
David C Dreyer director C/O SICOR INC, 19 HUGHES, IRVINE CA 92618-1902
Shawn Tomasello director C/O PHARMACYCLICS, INC, 995 EAST ARQUES AVENUE, SUNNYVALE CA 94085
Regina M. Benjamin director 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Benjamin Wolin director C/O EVERYDAY HEALTH, INC., 345 HUDSON STREET, 16TH FLOOR, NEW YORK NY 10014
Jeffrey G Park director C/O DIPLOMAT PHARMACY, INC., 4100 S. SAGINAW ST., FLINT MI 48507
Sean Whelan director, officer: Chief Financial Officer C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108
Jeffrey M Rowe director, officer: EVP of Operations C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018

Diplomat Pharmacy (Diplomat Pharmacy) Headlines

From GuruFocus

Diplomat Appoints Dave Loschinskey as Chief Operating Officer

By PRNewswire PRNewswire 05-07-2019